Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization.
Pranab Das(Lexington VA Health Care System), Khaled M. Ziada(Cleveland Clinic), David J. Moliterno(University of Kentucky), Debabrata Mukherjee(Texas Tech University), David C. Booth(University of Kentucky), Jeannie Sneed(University of Kentucky), Steven R. Steinhubl(Purdue University West Lafayette), Richard Charnigo(University of Kentucky)
PubMed
September 1, 2006
Cited by 69
Related Papers
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Circulation|2011|3.3k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2011|2.2k
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
|Journal of the American College of Cardiology|2016|1.6k